Sarah Cannon Research Institute Appoints Dr. Krish Patel as Director of Lymphoma Research
Slice of Healthcare Team
Nov 14, 2024
Key Highlights
- Krish Patel, MD, appointed as Director of Lymphoma Research at Sarah Cannon Research Institute (SCRI).
- Dr. Patel to enhance lymphoma clinical trial portfolio at SCRI's 250+ locations.
- Background includes roles at Swedish Cancer Institute and significant research publications in leading medical journals.
- Brings expertise in lymphoma, CLL, and cellular therapy.
Source: Business Wire
Notable Quote
“ We are pleased to welcome Dr. Patel as we continue our mission to provide cutting-edge clinical research in the community. Dr. Patel’s role will be pivotal in providing scientific leadership and oversight for our robust menu of lymphoma clinical trials, addressing a critical need with nearly 90,000 new U.S. cases of lymphoma estimated in 2023. ”
David Spigel, Chief Scientific Officer at SCRI
